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Obje&ves. This study was designed to characterize the nature 
and time course of carboxpterminal lysine cleavages from the 
creatine kinase (CK) in viva. 
Background. Rapid conversion of the tissue iSOfOrm Of MM CK 
to two additional circulating isoforms with one or both carboxy- 
terminal lysines cleaved facilitates early detection f new tissue 
isofurm release after acute myocardiai infarction and coronary 
recanalization. Characterization of changes in plasma MS CK 
isoform profiles, potentia~Iy enhancing specificity even further, 
has been hindered by difffcuities in separating the isoform prod. 
ucts and elucidation of carboxy.terminal lysine cleavages under- 
lying their formation. 
Metllods. Isoform species with carboxy-terminal lysine present 
on B.monomers were separated from those from which lysine had 
been cleaved by anion exchange chromatography. Carboxy 
terminal lysine on M.monomers was assayed with the use of a 
monospecific antibody. 
Results. MB CK in four pooled plasma samples from 
among 77 normal subjects exhibited carbox~termi~al lysine 
on 48 f 211% (mean * SEM) af &monomers and 82 f 12% of 
Further progress with interventions designed to restore 
coronary blood flow early in the course of acute myocardial 
infarction would be enhanced by methods for the rapid 
diagnosis of infarction and for detection of the occurrence 
and timing of coronary recanalization. Appearance ot the 
MB isoenzyme of creatine kinase (CK, EC 2.7.3.2) inplasma 
is a specific marker of acute myocardiai infarction (I). 
However, MB CK constitutes only 15% of the total CK 
activity in myocardiurr. (2) (the other 85% being MM CK), 
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30 h, 43 f 9% (three ~00~s fro 
95 f 10% of ~.moaolners 
terminus. After 40 to 50 h, I3 f 
of B-manamers and 46 9, 19% of M.mo~omers sti!l retained 
carbox~terminat lysine. 
~o~~~us~o~s. In contrast to CF.<, the tissue ~sofQr 
CK undergoes slow cleavage sine from both monomers m 
vivo. Sequential cleavage of lysi 
of ~-monomers and subsequen 
with generation of at least two a 
of assays capable of resolving all of the isofor 
cam occur in vivo might increase sensitivity for early detention of 
new tissue isoform release associated with acute myoeardial 
inIarctio~ and coronary reca~alizatio~ compared with cu 
and release of CK from myocardium undergoing infarction is
slow initially. Thus, plasma MB CK activity remains within 
the normal range for several hours after the onset of infarc- 
tion. Even after coronary recanaiization, plasma MB CK 
activity may increase too si~wiy to permit its rapid recogni- 
tion. 
After the initial report by Wevers et al. (3), it was 
discovered that once CK isoenzymes are released into the 
circulation, they undergo systematic biochemical modifica- 
tions that favor the arly detection of infarction and coro- 
nary recanalization (4-6). The nature of these modifications 
has beeE defined for the MM isoenzyme and entails sequen- 
tial, irreversible cleavage of a single iysine residue from the 
carboxyl terminus of each M-monomer, which is mediated 
by circulating carboxypeptidase N (7-11). This results in 
time-dependent conversion of the tissue iseform (MM,) to 
two additional enzymatically active isoforms with one or 
both lysine residues removed (MM, and MMI) and exhibit- 
ing a stepwise increase in negative charge, facilitating their 
separation by electrophoresis and chromatofocusing. Be- 
cause conversion toother isoforms i  rapid, MM, constitutes 
<20% of MM CK in plasma under physiologic conditions 
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has been consid- 
mers (19). This observation is consi 
isoforms analogous tothose seen 
three additional isoforms: two 
vivo and to define the time course of generation of 
isoform products in vivo. Assay techniques that d~stiogoish 
B-monomers on the basis of presence or absence ofcarboxy- 
terminal lysine and that detect -monomers with an intact 
carboxy terminal lysine permitted i re~tiatio~ f individ- 
real isoform species (19-2ii). 
col was approved by the uman Studies Committee at 
Washington University. All subjects gave written informed 
consent. Blood (60 to 120 ml) was withdrawn fro the 
antecubital vein of 77 healthy volunteers (one sample/ 
volunteer) into heparinized syringes (final concentration f 
20 U/ml), centrifuged at9,000 rpm for 15 min and the plasma 
removed. Plasma MB CK mass in individual subjects was 
verified to be in the normal range (17 PgIliter) and plasma 
from four groups of subjects was pooled (total volumes of 
900, I ,500, 890 and 1,070 ml). Each pool was assayed for 
isoforms of MB CK. 
Serial plasma samples were obtained from patients with 
acute myocardial infarction who bad neither received tbroor- 
bolytic drugs nor undergone any other revascularization 
procedure. Samples (3 to 6 ml) obtained from 6 to 10 patients 
at each of three intervals after the onset of symptoms (510, 
tive solid-phase radioi 
ues was asses 
eluted from the ” 
enzymatic activity of 
was remove 
tbe presence or absence of
indicative of isoforms with and without ~arboxy-terminal 
lysine on the B-monomer, the proportions of the isoforms 
were expressed as percentages of the total area under tbe 
absorbance profile. ln some samples with high 
ties, the peaks were s parated bypreparative 
phy of the remaining with monitoring o 
(A,,,) in the column e t and collection of the individual 
protein peaks. These dialyzed and concentrated. 
To detect the presence ofcarboxy-terminal lysine on the 
-monomer, isoforms eparated by actor-exchange chro- 
matography or the remaining sample not applied to the 
anion-exchange column were mixed with a rno~ospe~i~~ 
antibody that inhibits enzymatic activity of ~-monomers 
maximal i~~b~bitio~~ of CK activity. The of the 
antibody was assessed with MB C 
prepared as described in the following section. The 
CK-antibody mixture was mixed gently over~~~bt at 4°C. 
Inhibition of CK activity was expressed as a percentage of 
the activity in paired control samples containing an equiva- 
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lent volume of buffer (IO mmol/liter Tris, I mm@llliter 
2-mercaptoethanol, 0.2 mg/ml bovine serum albumin, pN 
7.4). 
Purification of individual isoenzymes from tissue. 
Both MM and MB CK were p ed from the native hearts 
excised from patients who were recipients of donor cardiac 
dlografts; BB CK was purified from human umbilical cord. 
Tissues were rinsed with ice-cold saline solution and frozen 
at -20°C before processing. Tissue MB CK was extracted 
from myocardium, asdescribed previously (231, except that 
precipitation f nor&K protein in the homogenate was done 
with 30% followed by 70% (weight/volume) ammonium 
sulfate, and the xtract was applied irectly to the “Conan- 
MB”-Scpharosc column. The etllueut was rerun through the 
affinity column to optimize binding of MB isoform to the 
antibody. The second cfflucnt, containing MM CK, was 
dialyzed against 50 mmollliter Tris, (pH 8.5) ovcraight at 4°C 
before further purification of the MM CK, as described 
previously (23). 
Tissue BB CK was purified as described previously (23) 
except that after the second ethanol precipitation (70%) [he 
crude extract was fractionated bya single anion-exchange 
chromatographic step on a column of Q-Sepharose 
(PharmaciaILKB). The column was eluted with a linear 
gradient of sodium chloride (0 to 500 mmol) and fractions 
eluting at 220 to 250 mmol sodium chloride containing 
BB CK activity were pooled, dialyzed overnight (4°C) and 
concentrated before freezing at -70°C. 
eparation of individual isoforms of M 
with lysine selectively removed from the carboxyl terminus 
d: either the M-monomer o the B-monomer were prepared 
as described previously (19). Briefly, MM CK and BB CK 
purified from tissue were thawed rapidly, equilibrated at
room temperature for5 mia and incubated with pancreatic 
cnrboxypeptidase !3 (Behring Diagnostics) in a mass ratio of 
I:25 (carboxypeptidase to CK) for 5 min at 22°C and 25 min 
at 4°C. The reaction was stopped by placing the mixture 
on ice. The resulting isoenzyme products were separated 
from carboxypeptidase B by anion-exchange chromatogra- 
phy (Q-Sepharosek with MM CK eluting from the column at 
60 mmol sodium chloride, carboxypeptidase B at100 mmol 
sodium chloride and BB CK at 240 mmol sodium chloride. 
Fractions containing CK activity were verified as devoid of 
residual carboxypeptidase ctivity with use of a spectropho- 
tometric assay (9). 
After dialysis and concentration, each repurified, 
::arboxypeptiaase-treated iso nzyme was mixed with an 
equivalent mass of the tissue isoenzyme of the opposite 
monomer (for example, MLys(_, MLysq_) with BLys(+) 
B tYs(+J. The mixtures were made 4 molar with guanidine 
hydrochloride, incubated for IO min at 22°C. and dialyzed 
against 50 mmoNiter Trk (pH 7) containing IO mmofliter of 
2-mercaptoethanol for 72 h at 4°C. The hybrid isoforms were 
separated from renatured MM and BB CK by preparative 
anion-exchange chromatography (Q-Sepharose). 
Figure 1. K&live affinity of “Conan-M ” for isoforms of creatine 
kinase (CK): MB fraction with ~arb~xy-germinal lysines intact 
(M ,+, , ,B,.y,c + ,, tissue isoform) and removed (MLy,(_,BLys,_,). lm- 
mobilized “Conan-MB” antibody was mixed with increasing con- 
centrations of MB CK proteins and 140,000 countslmin of iodine-125 
human MB CK. Radioactivity bound by the antibody at each 
concentration of MB CK protein is expressed relative to radioactiv- 
ity bound with no competitor present (BIBo). 
pled enzyme system (CK Single Vial 
nostics) and a miniature ccntrifug 
Electronucleonicsl. ResLIts were ex 
liter at 30°C. llmmunoadsorbant ass 
antibody (24’1 and a 
mere used for measurement of MB CK mass. Protein was 
assayed by a modified Lowry method (25). 
Specificity and sensithity of isoform assays. Competitive 
radioimmunoassay showed comparable ffinities of MB CK 
both with and without intact carboxy-terminal lysines for the 
“Conan-MB” antibody (Fig. I). Anion-exchange chroma- 
tography separated isoforms of MB CK on the basis of 
presence or absence of carboxy-termirdal lysine on the 
B-monomer, as reported previously (19). !soform standards 
generated by selective hybridization f purified isoenzymes 
containing carboxy-terminal lysine on the B-monomer with 
and without lysine on the M-monomer (MLys(+)BLys(+) and 
MI . _,BLys(+J co-eluted from the anion-exchange column 
at 4 sodium chloride concentration f 160 mA4 ( 
Isoforms with lysine removed from the B-monomer ( 
BLys(_) and MLys(-jBLys(-k) eluted at 190 mM of soLdyis:Fr: 
chloride whether or not the M-monomer contained a 
carboxy-terminal lysine (Fig. 2). Native MB CK purified 
from myocardium eluted at 160 m&f of sodium chloride. 
Incubation with pancreatic carboxypeptidase B, xpected to 
cleave the carboxy-terminal lysine from both monomers, 
resulted in elution of a single peak at 190 mM of sodium 
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Absorbance profiles of individual isofor 
fraction eluted from the anion-exe 
, Isoforms with carboxy-terminal lysiae present [Lys(t)j on 
-monomers co-eluted at a sodium chloride (WaCl) concentratiol~ of 
0 miM whether the lysin absent [Lys(-)I at the 
carboxyl terminus of the , lsoforms with lysine 
cleaved from the carboxyl monomers eluted al a 
sodium chloride concentrati gardless of tbe presence 
or absencr of lysine on the 
chloride. The lower limit of sensitivity of the assay was 
found to be 0.1 to 0.2 U of C activity with 0.05 U of activity 
detectable per isoform peak. 
Because antibody u 
ca~.boxy-tee 1 lysine on 
enzymatic activity of B-monomers, molar atios of 
to CK m5O:l consistently inhibited only 50% to 60% of the 
enzymatic activity of either of the two isoforms with car- 
boxy-terminal lysine pr sent on the -momomer (Fig. 3). 
Enzymatic activity was not inhi’oited at any concentration f 
antibody for isoforms with the carboxy-terminal lysine res- 
Figure 3. Inhibition of enzymatic activity of isoforms of creatine 
kinase (CK), MB fraction and the tissue isoform of
overnighl incubation with increasing molar atios of antibody 
(CKM-GOl). Activity was inhibited by approximately 50% for 
isoforms of MB CK with carboxy-terminal lysine present [Lys(t)] 
on M-monomers compared with 100% for the tissue isoform of MM 
CK (M,.ys(+, MW+I ) reflecting the specificity of the antibody for the 
M-monomer. Activity was not inhibited for isoforms with lysine 
absent [Lys(-)I from Ihe carboxyl terminus of M-monomers. 
Antibody to GK Molar Ratio 
M-monomer 
B-monomer 
~ocard~a~ Infarction (h) 
and B-monomers with the carboxy- 
terminal lysine residue present in normal subjects (average results from 
four pooled samples from 99 patients) and in patients at intervals after 
the onset of acute myocardial infarction (0 to 16 h, three pooled 
samples from 29 patients: 20 to 30 h, three pooled samples from 19 
patients; 40 to 50 h, four pooled samples from 34 patients). 
of the assay was approximately 
of lysine at the carboxyl 
-monomers, we found in plasma sa 
normal subjects that approximately 50% of circulatang 
monomer5 bad car y-terminal lysine residues (Fig. 4). 
ore than 80% of monomers had carboxy-terminal 
lysine. Early after myocardial infarction (516 h after the 
onset of symptoms) virtually all of the 
in plasma exhibited carboxy-terminal 
sistent with the release of tissue CK from infarcted 
myocardium and slow cleavage ofthe lysine residues. After 
20 bo 30 h, lysine residues had been cleaved from both 
ough more rapidly from B- than from 
rate of cleavage of lysine from 
proceeded more slowly com- 
pared with the rate of cleavage of lysine from ~-monomer§ 
comprising MM CK (Fig. 5) (9,ll). 
The results of this study show that both 
are subject o cleavage of lysine 
I lerminus in vivo. Cleavage 
CK occurs more rapidly with th 
-monomer (Fig. 4) but is remarkably slower t 
cleavage ofcarboxy-terminal lysine from either M-monomer 
of MM CK (Fig. 5). The data re consistent wi h sequential 
MM-lsoform 
B Analysis 
Pinure 5. Disoarats time courses of generation of isoforms of MB 
Ck (A) comp&d with MM CK (W-as shown by assay of pooled 
plasma from samples obtained 20 tu 30 h after the onset of 
myocardial infarction. Two peaks df enzymatic activity of MB CK 
separated by anion-exchange chromatography reflect isoforms wirh 
carboxy-terminal lysinc present (peak at 160 m&I sodium chloride 
[NaCl]) or absent (peak at 190 mM NaCI) from the B-monomer. 
Analysis of each peak with antibody specific for M-monomers (data 
not shown) demonstrated carboxy-terminal bfsine on 100% of 
M-monomers in the peak at 190 mM NaCl consistent with slower 
cleavage of iysine from M-monomers compared with B-monomers. 
S, Separation of isoforms of MM CK with chromatofocusing 
(26) indicated that cirav~ge of carboxy-terminal lysine proceeds 
much more rapidly, as is evident from the predominance of 
MM,, the isoform lacking lysine at the carboxyl terminus of both 
M-monomers. 
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MB-lsoform 
Analysis 
ptoresis (19). Migration of the fully converted &form with 
both carboxy-termina! lysines removed isgreater. Thus, the 
apparent existence ofonly two isoforms of 
detectable by electrophoresis (3,18,27) appears 
co-migration of the tissue isofoim with one or both of the 
presumptive intermediate species. The resulting incomplete 
separation of the tissue isoform from other isofor 
in the circulation could compromise nsitivity for detection 
of new tissue isoform release associated with acute m,vocar- 
dial infarction or coronary reca~a~~ati~~. 
11 NaCl (mM) 
conversion of the tissue isoform of MB CK first o an interme- 
diate isoform lacking carboxy-terminal lysine on the B-mono- 
mer and finally to a fully converted isoform lacking carboxy- 
terminal lysine on both monomers. Because changes in the 
ratios of individual isoforms of MM CK promptly reflect 
elaboration f the tissue isoform into plasma, nd accordingly 
the onset of acute myocardial inf rction (12-15) or coronary 
~c~~ization (16,17), characterization of a alogous changes in 
plasma profiles of isoforms of MB CK may enhance the 
specificity ofdetection. However, definitive interpretation of 
changes inplasma profiles of isoforms ofMB CK will require 
quantification of at least hree and perhaps four individual 
isofofms in plasma samples. 
Limitations of currently available wsays. Cleavage of 
lysine from the carboxyl terminus ofindividual monomers of
MB CK apparently does not affect he surface harge of the 
molecule inthe same way it does for MM CK, judging from 
the inadequate separation f isoforms by conventional meth- 
ods such as anion-exchange chromatography and electro- 
phoresis. Elution from an anion-exchange column is altered 
by hydrolysis of lysine from the B- but not the M-monomer 
(Fig. 21. In addition, removal of one carboxy-terminal lysine 
residue from the tissue isoform of MB CK (whether it comes 
from the M- or the B-monomer) only slightly increases 
migration of the molecule toward the anode during electro- 
hydrolysis of lysine from the B-rno~omcr~ and dimers 
absent on the B-monomer were therefore com- 
-monomers with carboxy-te 
present or absent, at least hree different i 
necessary toaccount for the observed pro 
mers retaining lysine. On the basis of these assumptions, 
temporal changes in the proportions of the three isoforms 
can be calculated (Table I). Although other combinations of 
monomers are possible, including contributions from the 
fourth isoform with carboxy-terminal lysine removed from 
only the M-monomer, sequential conversion is indicated by 
our data suggesting that hree rather than four isoforms exist 
in significant 
Potential e iso- 
forms. Unlike the cleavage of carboxy-terminal lysine from 
MM CK, which we have shown proceeds rapidly and at rates 
that are directly proportional to carboxypeptidase N activity 
in plasma (9,l I), cleavage of lysine from MB CK proceeded 
slowly in vivo (Fig. 4 and 5). The slow rate of removal of 
lysine tended to keep the proportions ofM- and B-monomers 
retaining lysine at the carboxyl terminus high under baseline 
conditions (Fig. 4, Table 1). For this reason and because of 
the relatively modest amount of MB CK activity in myocar- 
dium (2), it is not clear that he quantities ofMB CK released 
from myocardium early after myocardial infarction or soon 
after coronary recanalization will be sufficient to alter iso- 
form profiles markedly and as rapidly as is the case for 
isoforms of MM CK (12-17). Nevertheless, results of a 
recent study (27) suggest that changes in the ratio f the two 
bands of MB CK activity currently separable by ele 
resis precede asignificant increase of plasma total 
activity, permitting earlier detection of myocatdial infarc- 
tion. Our results indicate that the sensitivity of changes in 
MB CK isoform profiles may be even greater than that 
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Normal s;ubjecis 
Patients after infarction 
Qto 16h 
Xl to 30 h 
40 to 50 b 
*Calculated by assuming that all B-monomers with carboxy-terminal 
lysine are combined with M-monomers with carboxy-terminal lysine. tThe 
tissue isoform. 
enon known to induce a 
to be elucidated. The antibodies 
playing antibodies specific the tissue isoform or as 
capable of separation of the tissue isofonn from all other 
CirC isoform species may enhance greatly the sensitivity 
and city for detection ofacute myocardial nfarction and 
coronary recanalization. 
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